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Introduction
Bernard-Soulier Syndrome (BSS)is a rare hereditary disorder.Platelets in patients with BSS are unable to adhere, leading to an increased bleeding tendency. BSS cases are often misdiagnosed as idiopathic thrombocytopenic purpura (ITP). We report here a seven years old girl diagnosed as Bernard-Soulier syndrome with homozygous deletion of 39 nucleotides in the exon 2 of GP1BA. Bernard-Soulier syndrome should be considered before the patient is diagnosed with immune thrombocytopenia.
Bernard-Soulier syndrome (BSS) was first known by two French hematologists -Jean Bernard and pierresoulier. They found out a patient from a consanguineous family with severe bleeding episodes, thrombocytopenia and very large platelets [1] . It is a rare hereditary disorder (1:1000000) [2] .Platelets in patients with BSS are unable to adhere, leading to an increased bleeding tendency [3] .BSS is a platelet function disorder, transmitted in an autosomal recessive manner. Caused by defects in the glycoprotein (GP)Ib/IX/V complex [4] . These genes stand for a group of linked proteins normally found on the surface of the platelets [5] . Composed of four subunits, GPIbα disulphide-linked to two GPIbαβ subunits, GPIX and GPV in a ratio of 2:4:2:1, respectively [5] . The genes for each of these subunits have been cloned and are located in Chromosome (ch). 17p12 (GPIBA) [6] , ch.22q11.2 (GPIBB) [7] , ch3q21 (GP9) [8] and ch.3q29 (GP5) [9] . BSS cases are often misdiagnosed as idiopathic thrombocytopenic purpura (ITP) [5] . In this case report, we present one girl with causative mutations in GP1BA.
Case History:
A seven years old Saudi girl previously healthy until the age of 5 years old when she presented on 15/1/2015 complaining of petechiae all over face, chest, arms, abdomen, and legs. Another systemic review was unremarkable. She was not on any medications. On examination she was conscious, alert, oriented, not distress. No enlarged lymph nodes were palpable in any part of her body. Her abdomen was not distended, and her spleen and liver were not palpable other systemic examinations were unremarkable.
Laboratory finding were; CBC (HG: 11.7, RBC: 4.19, WBC: 11.2, PLATELET: 80).
Blood film: many large and giant platelets seen. Serologic examinations for Human Immunodeficiency Virus and hepatitis B and C were all negative. Also, ANA and direct coombs test were negative.
The patient diagnosed as idiopathic thrombocytopenia. Received IVIG and discharged in good condition.In addition, she had multiple admissions due to the same complain petechiae and low platelet count. She received IVIG many times, and she responded as platelet count increase at least by 30.000 but after two to four weeks platelets drop again even below 10.000. There was no respond to steroids. She responded to anti-D once for four weeks. She received four doses of rituximab there was no respond until 16 weeks. Bone marrow aspiration and biopsy were done on 30/3/2015 before receiving steroids; the result was cellular normal marrow. Normal megakaryocytes content on the marrow. No pathology on the marrow to explain the thrombocytopenia.
She was diagnosed as chronic ITP with frequent admission and poor response to treatment and due to hospital logistic issues platelets aggregation and flow cytometry not done.The doctor arranged an appointment for follow-up and genetic analysis for Bernard-Soulier syndrome. The result of Molecular genetic analysis of the genes GP1BA, GP1BB, GP9 showed a presence of a homozygous deletion of 39 nucleotides in the exon 2 of GP1BA. Finally, she diagnosed as Bernard-Soulier Syndrome (BSS).
